Immunosuppression of triptolide on skin allograft in mice

Junwei Yang,C. H. Chen,Zhihong Liu,Leishi Li

1997-01-01

Abstract:AIM: Triptergium Wilfordii Hook f. (TW) is a herb widely used in China to treat glomerular disease. Triptolide, one of the essential ingredient extracted from this plant, has been reported to be effective in inhibition of antigen or mitogen-induced T cell proliferation. Basing on these facts, we subjected triptolide to the skin allograft model in a dose response protocol. METHODS: Skin grafting was performed between BALB/e mice as recipient and C57BL/6 as donor. Immunosuppression was stratified from control with no immunosuppression to monotherapy with triptolide at 50, 100 and 200 ��g �� kg -1 �� d -1, with cyclosporine A (CsA) at 5, 10 and 20 mg �� kg -1 and to combined therapy with triptolide at 50 ��g �� kg -1 �� d -1 and CsA 5 mg �� kg -1 �� d -1 given orally respectively. Recipient mice were pretreated with triptolide and CsA for 14 days before skin transplantation. The grafts were then followed by daily visual inspection. RESULTS: The mean survival time (MST) of skin allograft to nonimmunosuppression controls (n-6) was 9.8 days. MST in groups treated with triptolide 100 and 200 ��g �� kg -1 �� d - 1 were longer than control: and so do CsA treated (10 and 20 mg �� kg -1 �� d -1) mice. All grafts in the combined therapy group survived for more than 20 days. CONCLUSION: Our study suggested that triptolide has considerable ability to blunt allograft immune responses in mice.